An obesity vaccine has shown promising results in a small animal study, according to a report in today’s Proceedings of the National Academy of Sciences. The vaccine targets the hormone ghrelin, which is produced in the stomach and plays a role in hunger and weight gain. Rats given the vaccine, which causes the immune system to attack and break down the hormone, eat the same amount of food as other rats but gain less weight. (Here’s the press release from the Scripps Research Institute, which conducted the study.)
While scientists have successfully identified several hormones involved in appetite, targeting those molecules to create successful weight-loss treatments has proven difficult. Ghrelin, for example, has complex effects: mice given it tend to eat more, but those who lack the hormone have normal appetites.
It’s unclear if the current results will translate to humans, who likely have more a complex appetite control system. But we may find out soon. Swiss biotech company Cytos is currently testing another type of ghrelin vaccine in humans. – By Emily Singer
Embracing CX in the metaverse
More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.
Identity protection is key to metaverse innovation
As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.
The modern enterprise imaging and data value chain
For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.
Scientists have created synthetic mouse embryos with developed brains
The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.